Publications by authors named "Cilin Yan"

Claim this Profile
H
Hepatitis B virus reactivation associated with Janus kinase (JAK) inhibitors: a retrospective study of pharmacovigilance databases and review of the literature.
Chen Pan, Mingnan Cao, Cilin Yan, Xiaojuan Ou, Xia Zhang

Expert Opin Drug Saf· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of potential pro-haemorrhagic drug interactions between CYP3A4 inhibitors and direct oral anticoagulants: Analysis of the FAERS database.
Dandan Li, Cilin Yan, Mingxing Guo, Ying Zhao, Yang Zhang

Br J Clin Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database.
Ye Xu, Cilin Yan, Ying Zhao, Dandan Li, Mingxing Guo

Cancer Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: A safety analysis from a literature review and a pharmacovigilance system.
Xiangli Cui, Cilin Yan, Ye Xu, Dandan Li, Mingxing Guo

Cancer Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haematopoietic cytopenia associated with cyclin-dependent kinase 4/6 inhibitors: A real-world study of data from the food and drug administration adverse event reporting system database.
Xiayang Ren, Cilin Yan, Le Tian, Xiangli Cui

Int J Immunopathol Pharmacol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis